Worth reading
54Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
38.6
Year-on-year change in revenue (%)Wording
Definitive
How definitive the wording is.Contents of this document
Financial results presentation2023年9月期 通期9 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥31,985 million+38.6%
Operating profit¥8,630 million+40.7%
Net income¥6,310 million+47.5%
Operating profit margin27.0%
Results for the three months of the current quarter
Net Sales
¥8,986 million
EBITDA
¥2,799 million
Operating profit
¥2,454 million
Profit attributable to owners of the parent
¥1,696 million
Full-year earnings forecast
Net Sales
¥42,638 million
EBITDA
¥12,340 million
Operating profit
¥10,500 million
Net income for the current fiscal year
¥7,255 million
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
Above planAssumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
- 平均定員数50名程度
- 安定稼働率82~85%
- 開設後の単月黒字化4~6ヶ月
- 開設後の累積黒字化10~12ヶ月
New initiatives
- 2024年9月期の27施設新規開設および1施設増床
- Amvis 2025目標の上方修正
- 医心館事業のノウハウを活用した地域医療再生事業への展開
Key KPIsA metric the company considers important as a management benchmark.
- 既存施設の稼働率86.7 %
- 新規施設の稼働率54.2 %
- 新規入居者数8,092 people
- 年間のがん患者受入数5,600 approximately people
- 施設内看取率（横浜市内8施設）100 %
Medium-term management plan targets
Plan nameAmvis 2025
Target fiscal yearFiscal year ended September 2025
Number of facilities131
Capacity6,621
Net Sales56,551
Revenue unit¥ million
EBITDA16,605
EBITDA unit¥ million
当期純利益年平均成長率25% or higher
Market Size / Share
- 一都道府県あたりの平均年間がん死亡者数（東京都）34,341 people
- 医心館の年間がん患者受入数の国内シェア1.4 Approximately %
- 年間のがん患者数400,000 people
Number of stores and locations
Number of facilities at period end76 Facility
Number of store openings and closures during the period23年9月期の新規開設数は資料上明示なし
Capital expenditures
¥9,837 millions purchases of property, plant and equipment
Annual Dividend
Annual dividend per share¥4
BreakdownOne year-end dividend per year
| Item | Details |
|---|---|
| Document type | Financial results presentation |
| Fiscal Period Covered | 2023年9月期 通期 |
| Net Sales | ¥31,985 million (YoY +38.6%) |
| Operating profit | ¥8,630 million (YoY +40.7%) |
| Net income | ¥6,310 million (YoY +47.5%) |
| Operating profit margin | 27.0% |
| Results for the three months of the current quarter | Net Sales ¥8,986 million / EBITDA ¥2,799 million / Operating profit ¥2,454 million / Profit attributable to owners of the parent ¥1,696 million |
| Full-year earnings forecast | Net Sales ¥42,638 million / EBITDA ¥12,340 million / Operating profit ¥10,500 million / Net income for the current fiscal year ¥7,255 million |
| Self-assessment against the plan | Above plan |
| Key KPIs | Indicator name 既存施設の稼働率 / Value 86.7 % / Year on year against the same period last year Not disclosed, Indicator name 新規施設の稼働率 / Value 54.2 % / Year on year against the same period last year Not disclosed, Indicator name 新規入居者数 / Value 8,092 people / Year on year against the same period last year Not disclosed, Indicator name 年間のがん患者受入数 / Value 5,600 approximately people / Year on year against the same period last year Not disclosed, Indicator name 施設内看取率（横浜市内8施設） / Value 100 % / Year on year against the same period last year Not disclosed |
| Number of stores and locations | Number of facilities at period end 76 Facility / Number of store openings and closures during the period 23年9月期の新規開設数は資料上明示なし |
| Assumptions Underlying the Business Outlook | Item 平均定員数 / Value 50名程度, Item 安定稼働率 / Value 82~85%, Item 開設後の単月黒字化 / Value 4~6ヶ月, Item 開設後の累積黒字化 / Value 10~12ヶ月 |
| Medium-term management plan targets | Plan name Amvis 2025 / Target fiscal year Fiscal year ended September 2025 / Number of facilities 131 / Capacity 6,621 / Net Sales 56,551 / Revenue unit ¥ million / EBITDA 16,605 / EBITDA unit ¥ million / 当期純利益年平均成長率 25% or higher |
| Annual Dividend | Annual dividend per share ¥4 / Breakdown One year-end dividend per year |
| Capital expenditures | ¥9,837 millions (purchases of property, plant and equipment) |
| Market Size / Share | Indicator name 一都道府県あたりの平均年間がん死亡者数（東京都） / Value 34,341 people, Indicator name 医心館の年間がん患者受入数の国内シェア / Value 1.4 Approximately %, Indicator name 年間のがん患者数 / Value 400,000 people |
| New initiatives | 2024年9月期の27施設新規開設および1施設増床, Amvis 2025目標の上方修正, 医心館事業のノウハウを活用した地域医療再生事業への展開 |
Items this document does not state (14)
Ordinary incomeGross Profit MarginSelling, general and administrative expensesProgress against full-year forecastSegment resultsBreakdown of Factors Affecting the ChangeUnit price and quantity metricsNumber of employeesRisk amount incorporated into the outlookFinancial targetsPayout ratioAcquisition of treasury sharesOrders received and order backlogKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.終末期ケアへの需要を背景に、既存施設の安定稼働と新規施設の早期立ち上がりが進んだ。加えて、コスト管理と必要に応じた入居費の値上げにより、インフレ環境下でも収益性を維持した。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.